Cargando…

Proteogenomic characterization and integrative analysis of glioblastoma multiforme

Glioblastoma multiforme (GBM), the most aggressive and lethal primary brain tumor, is characterized by very low life expectancy. Understanding the genomic and proteogenomic characteristics of GBM is essential for devising better therapeutic approaches.Here, we performed proteomic profiling of 8 GBM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Ying-Chun, Lu, Gai-Xia, Zhang, Hong-Wei, Zhong, Xiao-Ming, Cong, Xian-Ling, Xue, Shao-Bo, Kong, Rui, Li, Dan, Chang, Zheng-Yan, Wang, Xiao-Feng, Zhang, Yun-Jie, Sun, Ran, Chai, Li, Xie, Ru-Ting, Cai, Ming-Xiang, Sun, Ming, Mao, Wei-Qing, Yang, Hui-Qiong, Shao, Yun-Chao, Fan, Su-Yun, Wu, Ting-Miao, Xia, Qing, Lv, Zhong-Wei, Fu, David A., Ma, Yu-Shui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722563/ https://www.ncbi.nlm.nih.gov/pubmed/29228611 http://dx.doi.org/10.18632/oncotarget.21937

Ejemplares similares

Proteogenomic characterization and comprehensive integrative genomic analysis of human colorectal cancer liver metastasis
por: Ma, Yu-Shui, et al.
Publicado: (2018)

Correction to: Proteogenomic characterization and comprehensive integrative genomic analysis of human colorectal cancer liver metastasis
por: Ma, Yu-Shui, et al.
Publicado: (2019)

A Multi-Element Expression Score Is A Prognostic Factor In Glioblastoma Multiforme
por: Li, Jun-Qi, et al.
Publicado: (2019)

High expression of miR-105-1 positively correlates with clinical prognosis of hepatocellular carcinoma by targeting oncogene NCOA1
por: Ma, Yu-Shui, et al.
Publicado: (2017)

Proteogenomic characterization of ferroptosis regulators reveals therapeutic potential in glioblastoma
por: Wang, Xinzhuang, et al.
Publicado: (2023)

Nanosensitizers for sonodynamic therapy for glioblastoma multiforme: current progress and future perspectives
por: Guo, Qing-Long, et al.
Publicado: (2022)

EGFRvIII Promotes the Proneural–Mesenchymal Transition of Glioblastoma Multiforme and Reduces Its Sensitivity to Temozolomide by Regulating the NF-κB/ALDH1A3 Axis
por: Shi, Zhong-Fang, et al.
Publicado: (2023)

Exploring the Functional Roles of Telomere Maintenance 2 in the Tumorigenesis of Glioblastoma Multiforme and Drug Responsiveness to Temozolomide
por: Feng, Shao-Wei, et al.
Publicado: (2023)

Comparative proteogenomic characterization of glioblastoma
por: Asif, Samia, et al.
Publicado: (2019)

Glioblastoma multiforme: Effect of hypoxia and hypoxia inducible factors on therapeutic approaches
por: Huang, Wen-Juan, et al.
Publicado: (2016)

M6A RNA Methylation Regulator HNRNPC Contributes to Tumorigenesis and Predicts Prognosis in Glioblastoma Multiforme
por: Wang, Li-chong, et al.
Publicado: (2020)

MRI Manifestions Correlate with Survival of Glioblastoma Multiforme Patients
por: Li, Wen-bin, et al.
Publicado: (2012)

LOX-1+ PMN-MDSC enhances immune suppression which promotes glioblastoma multiforme progression
por: Chai, ErQing, et al.
Publicado: (2019)

Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development
por: Zhao, Hua-fu, et al.
Publicado: (2017)

Inhibition of USP14 Deubiquitinating Activity as a Potential Therapy for Tumors with p53 Deficiency
por: Ma, Yu-Shui, et al.
Publicado: (2020)

Identification of miR-124a as a novel diagnostic and prognostic biomarker in non-small cell lung cancer for chemotherapy
por: Luo, Pei, et al.
Publicado: (2017)

Developing the novel bioinformatics algorithms to systematically investigate the connections among survival time, key genes and proteins for Glioblastoma multiforme
por: You, Yujie, et al.
Publicado: (2020)

MicroRNA-302a/d inhibits the self-renewal capability and cell cycle entry of liver cancer stem cells by targeting the E2F7/AKT axis
por: Ma, Yu-Shui, et al.
Publicado: (2018)

Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021)

miR-135b Contributes to the Radioresistance by Targeting GSK3β in Human Glioblastoma Multiforme Cells
por: Xiao, Songhua, et al.
Publicado: (2014)

Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme
por: Jan, Chia-Ing, et al.
Publicado: (2018)

Apatinib for recurrent/progressive glioblastoma multiforme: A salvage option
por: Zhang, Hong-Hong, et al.
Publicado: (2022)

Honokiol-induced apoptosis and autophagy in glioblastoma multiforme cells
por: CHANG, KEN-HU, et al.
Publicado: (2013)

Low expression or hypermethylation of PLK2 might predict favorable prognosis for patients with glioblastoma multiforme
por: Xia, Xiangping, et al.
Publicado: (2019)

Cancer neoantigen prioritization through sensitive and reliable proteogenomics analysis
por: Wen, Bo, et al.
Publicado: (2020)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Comprehensive Analysis of the Brain-Expressed X-Link Protein Family in Glioblastoma Multiforme
por: Aisa, Adilai, et al.
Publicado: (2022)

Spinal metastasis of glioblastoma multiforme before gliosarcomatous transformation: a case report
por: Hsu, Bing-Hung, et al.
Publicado: (2020)

Ultra High-plex Spatial Proteogenomic Investigation of Giant Cell Glioblastoma Multiforme Immune Infiltrates Reveals Distinct Protein and RNA Expression Profiles
por: Bonnett, Shilah A., et al.
Publicado: (2023)

Characterization of natural peptides in Pheretima by integrating proteogenomics and label-free peptidomics
por: Luo, Xiaoxiao, et al.
Publicado: (2023)

Preoperative Prediction Nomogram Based on Integrated Profiling for Glioblastoma Multiforme in Glioma Patients
por: Wu, Wei, et al.
Publicado: (2020)

SNX8 modulates innate immune response to DNA virus by mediating trafficking and activation of MITA
por: Wei, Jin, et al.
Publicado: (2018)

Improving the Genome Annotation of Rhizoctonia solani Using Proteogenomics
por: Shu, Jiantao, et al.
Publicado: (2021)

Identification of a NFKBIA polymorphism associated with lower NFKBIA protein levels and poor survival outcomes in patients with glioblastoma multiforme
por: ZHAO, ZHAOHUI, et al.
Publicado: (2014)

Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)

Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme
por: Liu, Erheng, et al.
Publicado: (2023)

Morphometic analysis of TCGA glioblastoma multiforme
por: Chang, Hang, et al.
Publicado: (2011)

Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017)

Prediction of BRAF mutation status in glioblastoma multiforme by preoperative ring enhancement appearances on MRI
por: Cai, Xiaomin, et al.
Publicado: (2022)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gcghdcisqvapp0vo736ufc9jgq